Remicade (infliximab) - J&J
hydroxychloroquine - Generic mfg.
Taltz (ixekizumab) - Eli Lilly
Bimzelx (bimekizumab-bkzx) - UCB
Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Cimzia (certolizumab pegol) - Astellas, UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
5-fluorouracil - Generic mfg.
tofacitinib - Generic mfg.
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
chloroquine phosphate - Generic mfg.
Cibinqo (abrocitinib) - Pfizer
cyclosporine - Generic mfg.
Vtama (tapinarof) - Organon
Jakafi (ruxolitinib) - Incyte
Adbry (tralokinumab-ldrm) - LEO Pharma, AstraZeneca
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
roflumilast - Generic mfg.
Rinvoq (upadacitinib) - AbbVie
Nemluvio (nemolizumab-ilto) - Galderma
Dupixent (dupilumab) - Sanofi, Regeneron
azathioprine - Generic mfg.
apremilast - Generic mfg.
Sotyktu (deucravacitinib) - BMS
Enbrel (etanercept) - Pfizer, Amgen
Eucrisa (crisaborole) - Pfizer
http://clinicaltrials.gov/ct2/show/NCT07352566
 
Jun 4, 2026
 
Prev Next